The goal of this clinical trial is to is to investigate if it is possible to lower the chance of cancer reoccurrence and also preserve quality of life by using…

Malignant Neoplasm of ProstateLocally Advanced Prostate Cancer

~Estimated

~$10 – $7,500

Angela Y. Jia, MD PhDNCT06574880

Phase 1

Phase IB Trial of Relugolix and Enzalutamide as Neoadjuvant/ Adjuvant to Local-regional Treatment in Patients With High-risk Locally Advanced Prostate CAncer (RENAPCA)

The goal of this clinical trial is to test how effective and safe it is to use a combination of two medications, relugolix and enzalutamide, in patients with a…

Androgen Deprivation TherapyLocally Advanced Prostate Cancer

~Estimated

~$10 – $6,250

University of OklahomaNCT06130995